SCHEMBL4807741

SCHEMBL4807741

CCOC(=O)C(Cl)C(=O)Cc1ccc(Br)cc1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.42
MEN1 O00255 4/20 0.42
MAPK1 P28482 2/20 0.42
LMNA P02545 2/20 0.42
S1PR4 O95977 1/20 0.42
MAPT P10636 1/20 0.42
S1PR1 P21453 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
MME P08473 1/20 0.41
ACE P12821 1/20 0.41
KDM4E B2RXH2 1/20 0.40
GLA P06280 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SRD5A2 P31213 1/20 0.40
POLB P06746 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL622072 0.86 MAPT (0.49) KMT2AMEN1LMNAMAPTNPSR1
SCHEMBL3690028 0.84 MMP8 (0.48) KMT2AMEN1MAPK1LMNAMAPT
SCHEMBL7454217 0.83 HTT (0.49) KMT2AMEN1LMNAMAPTNPSR1
SCHEMBL8690626 0.80 MMP8 (0.48) KMT2AMEN1MAPK1MMEL3MBTL1
SCHEMBL8693477 0.79 KMT2A (0.43) KMT2AMEN1MAPK1LMNAS1PR4
SCHEMBL8692827 0.79 KMT2A (0.43) KMT2AMEN1MAPK1LMNAS1PR4
SCHEMBL4733 0.76 CYP1A2 (0.55) KMT2AMEN1MAPK1LMNAS1PR4
SCHEMBL8693497 0.76 MEN1 (0.44) KMT2AMEN1MAPK1L3MBTL1SMN1; SMN2
SCHEMBL8690146 0.76 MEN1 (0.44) KMT2AMEN1MAPK1MMEACE
SCHEMBL3232085 0.74 MAPT (0.50) KMT2AMEN1LMNAMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7449468-B2 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors SMITHKLINE BEECHAM CORPORATION (US) 2008-11-11 US disclosed
US-20070225294-A1 THIAZOLE AND OXAZOLE DERIVATIVES AS ACTIVATORS OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS BANKER PIERETTE 2007-09-27 US disclosed
US-7229998-B2 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors SMITHKLINE BEECHAM CORPORATION (US) 2007-06-12 US disclosed
US-20070072871-A1 THIAZOLE AND OXAZOLE DERIVATIVES AS ACTIVATORS OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS BANKER PIERETTE 2007-03-29 US disclosed
EP-1349843-B1 THIAZOLE AND OXAZOLE DERIVATIVES AS ACTIVATORS OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS SMITHKLINE BEECHAM CORP (US) 2005-04-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070072871-A1 THIAZOLE AND OXAZOLE DERIVATIVES AS ACTIVATORS OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS PPARD, PPARG, PPARA KMT2A 4234/4885MEN1 4766/4885MAPK1 2381/4885
US-20070225294-A1 THIAZOLE AND OXAZOLE DERIVATIVES AS ACTIVATORS OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS GPR119, PPARA, PPARG KMT2A 3815/4885MEN1 4456/4885MAPK1 1868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.